Advice

in the absence of a submission from the holder of the marketing authorisation

dexamethasone (Ozurdex ®) 0.7 mg intravitreal implant is not recommended for use within NHS Scotland.

Indication: Treatment of adult patients with inflammation of the posterior segment of the eye presenting as non-infectious uveitis.

The holder of the marketing authorisation has not made a submission to SMC regarding this product in this indication.  As a result we cannot recommend its use within NHSScotland.

Download detailed advice77KB (PDF)

Download

Medicine details

Medicine name:
dexamethasone (Ozurdex)
SMC ID:
751/11
Indication:
Treatment of adult patients with inflammation of the posterior segment of the eye presenting as non-infectious uveitis.
Pharmaceutical company
Allergan Ltd
BNF chapter
Eye
Submission type
Non submission
Status
Superseded
Date advice published
16 January 2012
Additional notes

NICE MTA Advice:  SMC Advice is superseded by National Institute for Health and Care Excellence (NICE) Multiple Technology Appraisal (MTA)